Dimar Kumala Puspaningrum
Department of Clinical Pathology, Faculty of Medicine, Universitas Islam Sultan Agung, Semarang, Indonesia

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Association of Hyperuricemia with Hypertension in Adult without Major Metabolic Comorbidities Intan Tri Hardini; Riefky Ihsan Pratama; Hesty Wahyuningsih; Dimar Kumala Puspaningrum; Dewi Intisari
Green Medical Journal Vol 8 No 1 (2026): Green Medical Journal
Publisher : Fakultas Kedokteran Universitas Muslim Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33096/azgh6141

Abstract

  Introduction: Hypertension is a major global health problem and a leading cause of cardiovascular morbidity and mortality. Hyperuricemia has been increasingly recognized as a potential metabolic factor associated with elevated blood pressure, although its independent role remains unclear, particularly in individuals without obesity, diabetes mellitus, or chronic kidney disease (CKD). Methods: Hypertension is a major global health problem and a leading cause of cardiovascular morbidity and mortality. Hyperuricemia has been increasingly recognized as a potential metabolic factor associated with elevated blood pressure, although its independent role remains unclear, particularly in individuals without obesity, diabetes mellitus, or chronic kidney disease (CKD). Result: Hypertension occurred in 72.5% of participants with hyperuricemia compared with 25.0% without hyperuricemia. Hyperuricemia was significantly associated with hypertension (p < 0.001; contingency coefficient = 0.429). Participants with hyperuricemia had a 2.91-fold higher risk of hypertension (RR = 2.91; 95% CI: 1.64–5.13). This association persisted across age groups, with RR = 2.41 (95% CI: 1.31–4.44) in participants aged <60 years and RR = 3.73 (95% CI: 1.25–11.16) in those aged ≥60 years. Conclusion: Hyperuricemia was associated with an increased risk of hypertension independent of major metabolic comorbidities and age, suggesting its potential role as an additional metabolic risk factor for hypertension.